AdvanCell entered into a strategic collaboration with Eli Lilly and Company; the transaction date was not available.
Deal value was 3300000000 (source: AI Estimation) Sector: Life Sciences; Location: Global.
On the seller side, legal counsel was not available; lawyers included Alison M. Lehner, Longbo Wang, Matthew D. Stoker, Rachel Kleinberg, Jonathan M. Westreich.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Sidley represents AdvanCell in expanded strategic collaboration with Eli Lilly | The Sponsor - The Sponsor